Eylea (Aflibercept)
What is a Generic Drug?
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Coming Soon – Save up to 85%
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Prescription Required
-
Product Details
Description
Eylea (aflibercept) is used to treat various types of eye conditions, including:
- Neovascular age-related macular degeneration
- Macular edema after retinal vein occlusion
- Diabetic macular edema
- Diabetic retinopathy
- Retinopathy of prematurity
Directions
Your healthcare provider will determine an appropriate dose and treatment duration for you based on the condition being treated. Eylea will be injected into the vitreous humor of the eye by your healthcare provider.
Ingredients
Aflibercept is the active ingredient in Eylea.
Contraindications
Patients with an infection of the eye, eyelid, or skin around the eye; eye inflammation; or an allergy to any of the ingredients in Eylea should avoid its use.
Cautions
- Before you begin treatment with Eylea, talk to your healthcare provider about:
- All the prescription and nonprescription medications you take, including eye drops or eye ointments
- Your allergies
- Your current health problems and past medical history
- Your pregnancy or breastfeeding status
- Infections inside the eye and retinal detachments can occur after intravitreal injections. Patients are recommended to inform their healthcare provider of any signs/symptoms of these effects.
- Increased intraocular pressure may occur within 1 hour of an intravitreal injection.
- Infants with retinopathy of immaturity will require extended monitoring.
- Blood clots may occur after intravitreal injections.
Side Effects
Conjunctival hemorrhage (bleeding), eye pain, cataract, vitreous detachment, vitreous floaters, and intraocular pressure are some common Eylea side effects. Tell your healthcare provider right away if you have side effects that bother you or won’t go away.
Ask your healthcare provider about Eylea.
Reference
- Eylea. Tarrytown, NY: Regeneron Pharmaceuticals, Inc.; 2023.
IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.Product Code : 14391
-
Product Reviews
